Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M17.1Revenue $M0.1Net Margin (%)--Altman Z-Score-331.2
Enterprise Value $M17.5EPS $-2.0Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-113.9Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-23.6Quick Ratio0.1Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-4.3Current Ratio0.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-410.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-1,138.7Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M11.1ROIC % (ttm)-1,105.5Gross Margin Increase y-yN

Gurus Latest Trades with ECTE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ECTECharles Brandes 2015-09-30 Sold Out $1.39 - $1.8
($1.59)
$ 1.54-3%Sold Out0
ECTECharles Brandes 2015-03-31 Buy $1.48 - $2.95
($2.34)
$ 1.54-34%New holding34,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ECTE is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ECTE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCHOENBART ALAN WAYNECFO AND SECRETARY 2015-05-20Buy2,500$1.446.94view
Hollander Scott WaynePRESIDENT AND CEO 2015-05-20Buy8,000$1.484.05view
Nordlicht Mark10% Owner 2014-06-30Buy65,739$2.2-30view
Nordlicht Mark10% Owner 2014-06-26Buy17,300$2.2-30view
Nordlicht Mark10% Owner 2014-06-24Buy16,961$2.2-30view
GOLDBERG MICHAEL M 2014-02-28Sell0$0-30view
Nordlicht Mark10% Owner 2013-12-10Buy69,569$2.75-44view
Platinum Partners Value Arbitr10% Owner 2013-07-11Sell0$0-44view
Doman Robert FDirector 2013-03-22Buy1,500$8-80.75view
GRIECO WILLIAMDirector 2013-03-21Buy3,000$7.6-79.74view

Quarterly/Annual Reports about ECTE:

    News about ECTE:

    Articles On GuruFocus.com
    5 Healthcare Picks for 2012 Mar 21 2012 

    More From Other Websites
    Echo Therapeutics Announces Final Closing of Private Placement of $5.1 Million of Convertible Notes... May 04 2016
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an... May 04 2016
    Echo Therapeutics Announces Significant Progress in Key Development Milestones May 04 2016
    Echo Therapeutics Announces Significant Progress in Key Development Milestones May 03 2016
    Echo Therapeutics Announces Conference Call to Provide an Update on Corporate Milestones Apr 28 2016
    Echo Therapeutics Announces Conference Call to Provide an Update on Corporate Milestones Apr 28 2016
    Echo Therapeutics Announces Voting Results of Special Meeting of Stockholders Apr 26 2016
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an... Apr 19 2016
    Echo Therapeutics Announces Voting Results of Special Meeting of Stockholders Apr 14 2016
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Apr 14 2016
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an... Apr 06 2016
    ECHO THERAPEUTICS, INC. Financials Apr 06 2016
    Echo Therapeutics, Inc. Announces 2015 Financial Results Mar 31 2016
    Echo Therapeutics, Inc. Announces 2015 Financial Results Mar 30 2016
    ECHO THERAPEUTICS, INC. Files SEC form 10-K, Annual Report Mar 30 2016
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an... Mar 22 2016
    Echo Therapeutics Says Nasdaq Granted Request to Remain Listed Mar 10 2016
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Mar 10 2016
    Echo Therapeutics Announces New Patents for Non-Invasive Sensing Technology Feb 22 2016
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an... Feb 12 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)